AbbVie Investment Purchases decreased by 58.6% to $1.16B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 35.2%, from $1.79B to $1.16B. Over 4 years (FY 2021 to FY 2025), Investment Purchases shows an upward trend with a 39.6% CAGR.
An increase indicates a surplus of cash being deployed into financial markets rather than core operations; a decrease may suggest a need for liquidity.
The total cash outflow for the acquisition of debt and equity securities, including marketable securities and other fina...
Large-cap technology firms often show high outflows here as they manage massive cash reserves across global portfolios.
cf_purchases_of_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $147.00M | $492.00M | $540.00M | $185.00M | $209.00M | $100.00M | $45.00M | $353.00M | $160.00M | $157.00M | $553.00M | $190.00M | $843.00M | $199.00M | $1.79B | $334.00M | $940.00M | $2.80B | $1.16B |
| QoQ Change | — | +234.7% | +9.8% | -65.7% | +13.0% | -52.2% | -55.0% | +684.4% | -54.7% | -1.9% | +252.2% | -65.6% | +343.7% | -76.4% | +800.5% | -81.4% | +181.4% | +198.1% | -58.6% |
| YoY Change | — | — | — | — | +42.2% | -79.7% | -91.7% | +90.8% | -23.4% | +57.0% | >999% | -46.2% | +426.9% | +26.8% | +224.1% | +75.8% | +11.5% | >999% | -35.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.